IOVA R&D Expenses
Iovance Biotherapeutics Inc · R&D Expenses
IOVA R&D Expenses
Latest reported$267.72Mperiod ending
IOVA TTM R&D Expenses ($11.00K → $267.72M)
TTM R&D Expenses
High-resolution chart · PNG
IOVA r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 267,715,000 | |
| 286,792,000 | |
| 300,270,000 | |
| 301,291,000 | |
| 294,362,000 | |
| 278,518,000 | |
| 282,336,000 | |
| 297,582,000 | |
| 316,863,000 | |
| 341,126,000 | |
| 344,077,000 | |
| 337,180,000 | |
| 322,156,000 | |
| 309,215,000 | |
| 294,781,000 | |
| 289,824,000 | |
| 282,677,000 | |
| 271,390,000 | |
| 259,039,000 | |
| 235,874,000 | |
| 213,569,000 | |
| 200,724,000 | |
| 201,727,000 | |
| 203,514,000 | |
| 202,046,000 | |
| 192,070,000 | |
| 166,023,000 | |
| 139,203,000 | |
| 125,568,000 | |
| 110,821,000 | |
| 99,828,000 | |
| 93,106,000 | |
| 82,912,000 | |
| 78,014,000 | |
| 74,725,000 | |
| 63,770,000 | |
| 54,498,000 | |
| 39,308,000 | |
| 26,877,000 | |
| 21,556,000 | |
| 18,058,000 | |
| 17,651,000 | |
| 15,470,000 | |
| 12,737,000 | |
| 8,107,879 | |
| 4,545,873 | |
| 2,837,535 | |
| 1,709,902 | |
| 1,606,023 | |
| 1,362,029 | |
| 1,329,367 | |
| 1,020,000 | |
| 1,020,000 | |
| 1,040,000 | |
| 1,656,000 | |
| 3,162,000 | |
| 2,912,000 | |
| 2,642,000 | |
| 1,756,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 11,000 | |
| 11,000 |